Nanomaterials and camel genes - which will be in future injections

Gradually, a new reality emerges and emerges - vaccination is just the beginning of a grand project involving the modification of humans at the gene level.

Recently, the first phase of surgery has been launched - mRNA technology, which transforms human cells and allegedly produces antibodies. But with that, the process does not stop and we are currently working on the next phase and they are nanomaterials. This is the new strategy they intend to ‘neutralize the virus’

In their study, so-called scientists have found two groups of molecules that are said to be effective against variants of the virus. Using a variety of mechanisms, these nanomaterials avoided mutations and blocked the virus from attaching to a receptor that allows it to enter cells.

It's all written in this science journal. It is said here that although vaccination has partially restored some pre-pandemic activities, the virus mutates rapidly, so new techniques are urgently being developed and this study shows that the new nanomaterials neutralize the Alpha, Beta and Gamma variants. This is an article written in June, so here's a note on some pre-pandemic activities - now in Israel and other countries it all starts all over again.

Companies have already begun to introduce new variants into their 'booster' poise concepts, says Kai Xu, an Ohio professor of veterinary bioscience and one of the authors of the study. But the virus is constantly changing and it may be faster than we can catch it. That is why we need a number of mechanisms to control it. An accelerated version of this study has already been published in the Natura journal.

What are nanomaterials? These are the antibodies that result from the immunization of camelids - camels, llamas and alpacas. They can be further transformed into molecules that replicate the structure and function of human antibodies.

As part of this process, the researchers immunized llamas and also 'nanopice' or transgenic mice with these camel genes, which in turn produced antibodies similar to those of camels. The team amplified these nanomaterials by first injecting the animals with the portion of the peak protein responsible for binding to the receptor in the cell, then with a booster pot that already contains all of the peak protein.

This is called a sequential immunization strategy, and in this way they have created nanotubes that recognize exactly the section of the peak protein that tries to bind to the cell receptor.

This is what a battle with the virus looks like - we can expect new syringes with camel genes and antibodies produced by GMO mice soon, which will save us all from the vicious ailments.